VTVT logo

VTv Therapeutics (VTVT) EBITDA

Annual EBITDA

-$25.86 M
-$1.10 M-4.43%

December 31, 2023

Summary

Performance

1-Year Change

-4.43%

3-Year Change

-115.24%

5-Year Change

-28.44%

15-Year Change

+48.84%

VTVT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.89%
VTVT annual EBITDA is higher than 46.89% of companies in Healthcare sector

High & Low

All-time High

-$12.02 M

3-Year Low

-$25.86 M
VTVT annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VTVT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
VTVT next annual earnings announcement is scheduled for Mar 13, 2025

OtherVTVTprofitabilitymetrics:

Annual Revenue

-
VTVT annual revenue value is unknown

Annual Net Income

-$20.25 M
VTVT annual net profit is -$20.25 million

Annual EBIT

-$25.95 M
VTVT annual earnings before interest & taxes is -$25.95 million

Annual EPS

-$9.71
VTVT annual earnings per share is -$9.71

Quarterly EBITDA

-$5.82 M
+$568.00 K+8.89%

September 30, 2024

Summary

Performance

3-Month Change

+8.89%

1-Year Change

+8.89%

3-Year Change

+19.04%

5-Year Change

-22.56%

VTVT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.75%
VTVT quarterly EBITDA is higher than 44.75% of companies in Healthcare sector

High & Low

All-time High

$1.70 M
VTVT quarterly EBITDA is currently -443.04% below its historical high of $1.70 million

3-Year Low

-$9.46 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VTVT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
VTVT next earnings announcement is scheduled for Mar 13, 2025

OtherVTVTprofitabilitymetrics:

Quarterly Revenue

-
VTVT quarterly revenue value is unknown

Quarterly Net Income

-$4.78 M
VTVT quarterly net profit is -$4.78 million

Quarterly EBIT

-$5.84 M
VTVT quarterly earnings before interest & taxes is -$5.84 million

Quarterly EPS

-$0.88
VTVT quarterly earnings per share is -$0.88

TTM EBITDA

-$22.22 M
+$2.70 M+10.82%

September 30, 2024

Summary

Performance

3-Month Change

+10.82%

1-Year Change

+10.82%

3-Year Change

+14.83%

5-Year Change

+6.83%

VTVT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.03%
VTVT TTM EBITDA is higher than 48.03% of companies in Healthcare sector

High & Low

All-time High

-$6.36 M

3-Year Low

-$29.17 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VTVT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
VTVT next earnings announcement is scheduled for Mar 13, 2025

OtherVTVTprofitabilitymetrics:

TTM Revenue

-
VTVT TTM revenue value is unknown

TTM Net Income

-$18.31 M
VTVT TTM net profit is -$18.31 million

TTM EBIT

-$22.31 M
VTVT TTM earnings before interest & taxes is -$22.31 million

TTM EPS

-$4.53
VTVT TTM earnings per share is -$4.53

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$25.86 M
VTVT annual EBITDA is -$25.86 million

Annual Net Income

-$20.25 M
VTVT annual net profit is -$20.25 million

Annual Interest Expense

$13.00 K
VTVT annual interest expense is $13.00 thousand

Annual Income Tax

$0.00
VTVT annual income tax is $0.00

Annual D&A

$90.00 K
VTVT annual depreciation & amortization is $90.00 thousand

VTVT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-4.4%+8.9%+10.8%
3 y3 years-115.2%+19.0%+14.8%
5 y5 years-28.4%-22.6%+6.8%

VTVT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-47.7%at low-43.0%+38.5%-26.9%+23.8%
5 y5-year-115.2%at low-443.0%+38.5%-249.2%+23.8%
alltimeall time-115.2%+52.7%-443.0%+60.0%-249.2%+59.5%

VTv Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.82 M(-8.9%)
-$22.22 M(-10.8%)
Jun 2024
-
-$6.39 M(+13.9%)
-$24.92 M(-3.1%)
Mar 2024
-
-$5.61 M(+27.1%)
-$25.72 M(-6.5%)
Dec 2023
-$25.86 M(+4.4%)
-$4.41 M(-48.2%)
-$27.52 M(-5.7%)
Sep 2023
-
-$8.51 M(+18.5%)
-$29.17 M(+11.8%)
Jun 2023
-
-$7.19 M(-3.0%)
-$26.09 M(+13.6%)
Mar 2023
-
-$7.41 M(+22.2%)
-$22.97 M(-7.2%)
Dec 2022
-$24.77 M(+41.4%)
-$6.06 M(+11.5%)
-$24.77 M(-12.1%)
Sep 2022
-
-$5.44 M(+33.6%)
-$28.16 M(+17.0%)
Jun 2022
-
-$4.07 M(-55.8%)
-$24.06 M(+15.6%)
Mar 2022
-
-$9.20 M(-2.7%)
-$20.81 M(+18.8%)
Dec 2021
-$17.52 M(+45.8%)
-$9.46 M(+607.2%)
-$17.52 M(+175.2%)
Sep 2021
-
-$1.34 M(+63.2%)
-$6.36 M(-9.4%)
Jun 2021
-
-$819.00 K(-86.1%)
-$7.02 M(-35.9%)
Mar 2021
-
-$5.90 M(-448.1%)
-$10.95 M(-8.9%)
Dec 2020
-$12.02 M(-39.8%)
$1.70 M(-185.0%)
-$12.02 M(-40.8%)
Sep 2020
-
-$2.00 M(-58.0%)
-$20.30 M(-14.9%)
Jun 2020
-
-$4.75 M(-31.9%)
-$23.85 M(+1.1%)
Mar 2020
-
-$6.97 M(+5.9%)
-$23.59 M(+18.1%)
Dec 2019
-$19.97 M
-$6.58 M(+18.7%)
-$19.97 M(+34.3%)
Sep 2019
-
-$5.55 M(+23.5%)
-$14.87 M(+42.6%)
Jun 2019
-
-$4.49 M(+34.2%)
-$10.43 M(-27.7%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$3.35 M(+126.5%)
-$14.42 M(-28.4%)
Dec 2018
-$20.14 M(-60.2%)
-$1.48 M(+33.3%)
-$20.14 M(-36.2%)
Sep 2018
-
-$1.11 M(-86.9%)
-$31.55 M(-24.7%)
Jun 2018
-
-$8.49 M(-6.4%)
-$41.90 M(-8.8%)
Mar 2018
-
-$9.06 M(-29.7%)
-$45.95 M(-9.1%)
Dec 2017
-$50.56 M(-7.6%)
-$12.89 M(+12.5%)
-$50.56 M(-0.7%)
Sep 2017
-
-$11.46 M(-8.6%)
-$50.93 M(-3.7%)
Jun 2017
-
-$12.53 M(-8.4%)
-$52.91 M(-3.7%)
Mar 2017
-
-$13.68 M(+3.1%)
-$54.93 M(+0.4%)
Dec 2016
-$54.69 M(+40.8%)
-$13.27 M(-1.3%)
-$54.69 M(+4.5%)
Sep 2016
-
-$13.44 M(-7.6%)
-$52.32 M(+8.4%)
Jun 2016
-
-$14.55 M(+8.2%)
-$48.26 M(+11.8%)
Mar 2016
-
-$13.44 M(+23.3%)
-$43.17 M(+11.2%)
Dec 2015
-$38.83 M(+32.9%)
-$10.90 M(+16.2%)
-$38.83 M(+10.6%)
Sep 2015
-
-$9.38 M(-0.8%)
-$35.12 M(+12.6%)
Jun 2015
-
-$9.45 M(+3.9%)
-$31.18 M(+8.0%)
Mar 2015
-
-$9.10 M(+26.5%)
-$28.86 M(-1.3%)
Dec 2014
-$29.22 M(-17.2%)
-$7.19 M(+32.2%)
-$29.22 M(+32.6%)
Sep 2014
-
-$5.44 M(-23.7%)
-$22.03 M(+32.8%)
Jun 2014
-
-$7.13 M(-24.6%)
-$16.59 M(+75.4%)
Mar 2014
-
-$9.46 M
-$9.46 M
Dec 2013
-$35.30 M
-
-

FAQ

  • What is vTv Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for vTv Therapeutics?
  • What is vTv Therapeutics annual EBITDA year-on-year change?
  • What is vTv Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for vTv Therapeutics?
  • What is vTv Therapeutics quarterly EBITDA year-on-year change?
  • What is vTv Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for vTv Therapeutics?
  • What is vTv Therapeutics TTM EBITDA year-on-year change?

What is vTv Therapeutics annual EBITDA?

The current annual EBITDA of VTVT is -$25.86 M

What is the all time high annual EBITDA for vTv Therapeutics?

vTv Therapeutics all-time high annual EBITDA is -$12.02 M

What is vTv Therapeutics annual EBITDA year-on-year change?

Over the past year, VTVT annual EBITDA has changed by -$1.10 M (-4.43%)

What is vTv Therapeutics quarterly EBITDA?

The current quarterly EBITDA of VTVT is -$5.82 M

What is the all time high quarterly EBITDA for vTv Therapeutics?

vTv Therapeutics all-time high quarterly EBITDA is $1.70 M

What is vTv Therapeutics quarterly EBITDA year-on-year change?

Over the past year, VTVT quarterly EBITDA has changed by +$568.00 K (+8.89%)

What is vTv Therapeutics TTM EBITDA?

The current TTM EBITDA of VTVT is -$22.22 M

What is the all time high TTM EBITDA for vTv Therapeutics?

vTv Therapeutics all-time high TTM EBITDA is -$6.36 M

What is vTv Therapeutics TTM EBITDA year-on-year change?

Over the past year, VTVT TTM EBITDA has changed by +$2.70 M (+10.82%)